- Home
- ARKO vs FHTX Comparison
ARKO vs FHTX Comparison
Compare ARKO & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARKO | FHTX |
|---|---|---|
| Founded | 1970 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Medicinal Chemicals and Botanical Products |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 490.3M | 419.9M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ARKO | FHTX |
|---|---|---|
| Price | $4.74 | $5.16 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $7.50 | ★ $11.50 |
| AVG Volume (30 Days) | ★ 1.2M | 364.2K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.91% | N/A |
| EPS Growth | 15.38 | ★ 25.32 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $9,142,799,000.00 | $30,909,000.00 |
| Revenue This Year | $12.86 | $8.89 |
| Revenue Next Year | $1.49 | $20.13 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 23.26 | ★ 36.75 |
| 52 Week Low | $3.71 | $3.27 |
| 52 Week High | $8.76 | $7.61 |
Technical Indicators
Market Signals| Indicator | ARKO | FHTX |
|---|---|---|
| Relative Strength Index (RSI) | 36.34 | 35.83 |
| Support Level | $4.20 | $4.43 |
| Resistance Level | $5.26 | $5.45 |
| Average True Range (ATR) | 0.19 | 0.48 |
| MACD | 0.11 | -0.23 |
| Stochastic Oscillator | 65.19 | 5.37 |
Price Performance
Historical ComparisonAbout ARKO ARKO Corp.
ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. It derives the majority of its revenue from retail and wholesale distribution of fuel.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.